GLENDALE, Calif., July 27, 2016 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed" or "the Company") (OTC: AMEH), an integrated population health management company, today announced that it has entered into management services agreements with APCN ACO, Inc. and Allied Physicians ACO, LLC to provide end-to-end population health management solutions, leveraging off ApolloMed ACO's expertise, processes and success within the Medicare Shared Savings Program ("MSSP") since 2012.
APCN ACO, based in San Gabriel, California, has been participating in the MSSP program since January 2013 and is comprised of 186 physicians and advanced practitioners with nearly 11,000 Medicare beneficiaries. Allied Physicians ACO, based in Alhambra, California, has been participating in the MSSP program since January 2014 and is comprised of 93 providers and 5000 Medicare beneficiaries.
As part of the agreements, the two ACOs will utilize ApolloMed's population health management platform to provide the following solutions:
- Quality reporting (GPRO reporting) and optimization
- Comprehensive analytics, including financial and quality metrics
- HCC coding optimization and risk-stratification of patients
- Hospitalist, transitional care and post-acute care services and consulting
- Hospice and palliative care services
- Home health and hospital-at-home services
- Physician engagement
- Patient engagement and satisfaction surveys
- Evidence-based digital care plans and care management module through the Apollo Care Connect platform
- Liaison with the Centers for Medicare & Medicaid Services ("CMS")
"We are very pleased to be the population health management solutions partner of choice for APCN ACO and Allied Physicians ACO," stated Warren Hosseinion, M.D., Chief Executive Officer of Apollo Medical Holdings. "Our goal is to be a national leader in the transformation of healthcare systems from fee-for-service to value- and outcomes-based care. We look forward to welcoming more provider organizations onto our population health and risk-management platform in 2016."
"Partnering with ApolloMed will help us deliver the best and most efficient care to our patients," stated Wei Wang, M.D., Chief Executive Officer of APCN ACO. "Their unique combination of an intuitive technology platform and clinical solutions compelled us to change management companies."
About Apollo Medical Holdings, Inc.
Founded in 2001 and headquartered in Glendale, California, ApolloMed is an integrated population health management company committed to providing exceptional multi-disciplinary care in the communities it serves. ApolloMed is addressing the healthcare needs of its patients by leveraging its integrated healthcare delivery platform comprised of six affiliated and complementary subsidiaries: ApolloMed Hospitalists, ApolloMed ACO (Accountable Care Organization), Maverick Medical Group (Independent Physician Association), Apollo Care Connect, Apollo Medical Management and Apollo Palliative Services. ApolloMed strives to improve medical outcomes with high-quality, cost-efficient care. For more information, please visit www.apollomed.net
Forward Looking Statements
This press release may contain forward-looking statements, including information about management's view of future expectations, plans and prospects for Apollo Medical Holdings, Inc. ("the Company"). In particular, when used in the preceding discussion, the words "predicts," "believes," "expects," "intends," "seeks," "estimates," "plans," "anticipates," and similar conditional expressions or future or conditional verbs such as "will," "may," "might," "should," "would" and "could" are intended to identify forward-looking statements. In addition, our representatives may from time to time make oral forward-looking statements. Any such statements, other than those of historical fact, about an action, event or development, are forward-looking statements. Such statements are based on the current expectations and certain assumptions of the Company's management. Such statements are, therefore, subject to a variety of known and unknown risks, uncertainties and other factors, many of which are beyond the control of the Company, which could cause the actual results, performance or achievements of the Company, its subsidiaries and concepts to be materially different than those that may be expressed or implied in such statements or anticipated on the basis of historical trends. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, the Company's actual results, performance or achievements may vary materially from those described in the relevant forward-looking statement as being expected, anticipated, intended, planned, believed, sought, estimated or projected. Unknown or unpredictable factors also could have material adverse effects on the Company's future results. The forward-looking statements included herein are made only as of the date hereof. The Company cannot guarantee future results, levels of activity, performance or achievements. Accordingly, you should not place undue reliance on these forward-looking statements. Finally, the Company undertakes no obligation to update or revise these forward-looking statements to reflect the impact of circumstances or events that arise after the date the forward-looking statement was made, except as required by law, and also takes no obligation to update or correct information prepared by third parties that are not paid for by the Company. You should not place undue reliance on any forward-looking statement and should consider the uncertainties and risks discussed under Item 1A. "Risk Factors" of the Company's Annual Report on Form 10-K for the year ended March 31, 2016 and in any of the Company's other subsequent Securities and Exchange Commission filings.
FOR ADDITIONAL INFORMATION
818-839-5200 or via email at [email protected]
SOURCE Apollo Medical Holdings, Inc.